Ultralow Dose of Nivolumab Offers Huge Cost Savings
A clinical trial from India raises the possibility of huge cost savings by using ultralow immunotherapy doses in the treatment of head and neck cancer.
Stay updated with breaking news from Ancer Prostate . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A clinical trial from India raises the possibility of huge cost savings by using ultralow immunotherapy doses in the treatment of head and neck cancer.
Nearly a third of men with prostate cancer had a vertebral fracture at the time of ADT initiation, underscoring the need for better baseline risk assessment.
The latest American Cancer Society annual report highlights an increase in late-stage prostate cancer diagnoses, but also a dramatic fall in cervical cancer in young women.
Despite guidelines against screening for prostate cancer in men aged 70 years and older, new findings show that the practice is still prevalent in the primary care setting.
Regular screening is recommended for only four cancers, but even so these tests account for diagnoses of about 14% of all cancers, a new study suggests.